Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced ...

Innovative radiotherapy offers a precision treatment alternative.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia. Novartis’ Scemblix (asciminib) has received accelerated approval by the US FDA as a ...

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and obese adults with heart disease. Novo Nordisk has released data from the ...